Feline Hyperaldosteronism: Diagnosis, Treatment, And Prognosis

Primary hyperaldosteronism, commonly referred to as Conn’s syndrome in veterinary medicine, represents a significant yet frequently underrecognized endocrine disorder in domestic cats. This condition arises from the overproduction of aldosterone, a key mineralocorticoid hormone produced by the adrenal glands. Unlike normal physiological responses, this excess secretion occurs autonomously, bypassing typical regulatory mechanisms like the renin-angiotensin-aldosterone system (RAAS). Predominantly affecting middle-aged to senior cats, it leads to a cascade of electrolyte imbalances, cardiovascular strain, and renal complications that can drastically impact a cat’s quality of life if left untreated.

Understanding the Adrenal Glands and Aldosterone’s Role

The adrenal glands, small triangular structures perched atop each kidney, play a crucial role in hormonal regulation. Composed of an outer cortex and inner medulla, the cortex is subdivided into zones, with the zona glomerulosa responsible for aldosterone synthesis. Aldosterone maintains electrolyte balance by promoting sodium reabsorption and potassium excretion in the kidneys, while also influencing blood pressure through fluid volume control.

In health, aldosterone release is tightly controlled by the RAAS, activated during low blood volume or pressure scenarios. However, in primary hyperaldosteronism, this control is lost, resulting in unchecked hormone levels. This disrupts homeostasis, causing potassium depletion (hypokalemia) and sodium retention, which expands blood volume and elevates systemic blood pressure (hypertension).

Root Causes of Excess Aldosterone in Cats

The primary driver in most feline cases is an adrenocortical adenoma or carcinoma—benign or malignant tumors within the adrenal cortex that autonomously secrete aldosterone, often alongside other mineralocorticoids. These neoplasms are typically unilateral, though bilateral involvement occurs less commonly. In rarer instances, idiopathic bilateral hyperplasia of the zona glomerulosa cells leads to similar overproduction without a discrete mass.

Secondary hyperaldosteronism, by contrast, stems from extracortical issues like severe heart failure or liver disease that stimulate RAAS activation. However, the focus here is primary form, which dominates veterinary reports. No specific breed, sex, or strong genetic predispositions have been identified, though older cats (average age 10-13 years) are most susceptible.

Recognizing Clinical Manifestations

Cats with this disorder often present subtly at first, masking the severity until advanced stages. The hallmark effects stem from hypokalemia and hypertension, manifesting as:

• Muscle weakness and lethargy: Owners frequently note generalized fatigue, reluctance to jump, or episodic collapse. Severe cases feature cervical ventroflexion—the inability to lift the head due to neck muscle paresis—or a plantigrade stance where hindlimbs flatten to the ground.
• Hypertension-related issues: Elevated blood pressure damages target organs, particularly the eyes, leading to mydriasis (dilated pupils), hyphema (blood in the anterior chamber), retinal detachment, and sudden blindness. Cardiovascular strain may cause heart murmurs or left ventricular hypertrophy over time.
• Polyuria and polydipsia (PU/PD): Increased thirst and urination arise from hypokalemia-induced nephrogenic diabetes insipidus or concurrent chronic kidney disease (CKD).
• Gastrointestinal disturbances: Anorexia, vomiting, or weight loss can accompany, though less specific.

Physical exams may reveal a palpable abdominal mass in tumor cases, alongside ocular abnormalities or cardiac changes. Notably, not all cats exhibit every sign; some present with isolated hypertension or mild hypokalemia, complicating initial recognition.

Laboratory and Diagnostic Insights

Routine bloodwork is pivotal, revealing:

Definitive diagnosis hinges on measuring plasma aldosterone concentration (PAC)—elevated inappropriately alongside low plasma renin activity (PRA), confirming primary overproduction. Ultrasound imaging detects adrenal masses (often >4mm, unilateral), calcification, or altered echogenicity. Blood pressure measurement is essential, with systolic values >160 mmHg signaling pathology. Advanced imaging like CT may delineate malignancy.

Differential Diagnoses to Consider

Several conditions mimic hyperaldosteronism:

• CKD: Causes hypokalemia and hypertension but with high renin.
• Primary hypertension: Lacks electrolyte shifts.
• Hyperthyroidism: Overlaps with PU/PD, weight loss.
• Diabetes mellitus: If co-secreting glucocorticoids present.

Distinguishing requires aldosterone-renin ratio testing.

Treatment Strategies: Surgical and Medical Options

Surgical Intervention

Adrenalectomy—removal of the affected gland—offers the best long-term cure for unilateral tumors. Preoperative stabilization with potassium supplementation (IV/oral), antihypertensives (e.g., amlodipine), and spironolactone (aldosterone antagonist) is critical to mitigate surgical risks like hypokalemic crisis or hemorrhage. Success rates exceed 80%, with normotension and normokalemia achieved in most survivors. Complications include contralateral hyperplasia or metastasis in malignant cases.

Medical Management

For inoperable tumors, bilateral disease, or metastasis, lifelong therapy targets symptoms:

• Spironolactone: 2-4 mg/kg BID; blocks aldosterone receptors, conserving potassium.
• Potassium supplements: Oral gluconate to maintain >3.5 mEq/L.
• Antihypertensives: Amlodipine (0.625-1.25 mg SID) for blood pressure control.
• ACE inhibitors: Adjunctive for renin suppression in select cases.

Monitoring includes serial electrolytes, blood pressure, and imaging.

Prognosis and Long-Term Outlook

Early intervention dramatically improves survival. Surgical patients often enjoy 2-4 years post-op with resolved symptoms, though CKD progression may limit lifespan. Medically managed cats stabilize but rarely achieve full remission, with survival averaging 1-2 years. Untreated, the disease progresses to fatal hypertensive crisis or renal failure. Regular vet check-ups are vital for ongoing care.

Preventive Measures and Owner Education

While not fully preventable, routine senior cat screenings for blood pressure, electrolytes, and renal function aid early detection. Owners should watch for weakness, blindness, or increased thirst, prompting prompt veterinary evaluation. Nutritional potassium-enriched diets may support at-risk cats.

Frequently Asked Questions (FAQs)

What is the most common age for feline hyperaldosteronism?

Middle-aged to older cats, typically 10-13 years, are most affected.

Can my cat recover fully from this condition?

Yes, with unilateral tumor removal, many cats achieve complete resolution of signs.

Is hypokalemia always present?

No, though seen in ~50-90% of cases; hypertension may be the sole initial sign.

How is the condition diagnosed at home?

It cannot; requires veterinary blood tests, imaging, and hormone assays.

What diet helps manage hypokalemia?

Prescription renal diets with added potassium under vet guidance.

Key Takeaways for Cat Owners and Veterinarians

• Underdiagnosed in azotemic senior cats—always check aldosterone if hypokalemic/hypertensive.
• Early treatment halves morbidity from renal/cardiac damage.
• Surgery preferred; medical options viable alternatives.

Similar Articles

Breathing Challenges in Flat-Faced Dogs

Diabetes in Dogs Guide

Nighttime Safety for Outdoor Cats

Managing Resource Guarding in Dogs

Cat Kneading Explained

Adding a Second Dog: Key Decisions

Author

medha deb

 

Medha Deb is an editor with a master's degree in Applied Linguistics from the University of Hyderabad. She believes that her qualification has helped her develop a deep understanding of language and its application in various contexts.

Read full bio of medha deb